180 related articles for article (PubMed ID: 16881074)
1. A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer.
Yazbek J; Aslam N; Tailor A; Hillaby K; Raju KS; Jurkovic D
Ultrasound Obstet Gynecol; 2006 Sep; 28(3):320-4. PubMed ID: 16881074
[TBL] [Abstract][Full Text] [Related]
2. Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology.
Van Holsbeke C; Van Belle V; Leone FP; Guerriero S; Paladini D; Melis GB; Greggi S; Fischerova D; De Jonge E; Neven P; Bourne T; Valentin L; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2010 Jul; 36(1):81-7. PubMed ID: 20217895
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors.
Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Thongsuksai P; Jaroenchainon P; Jivangkul C
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S22-30. PubMed ID: 17718292
[TBL] [Abstract][Full Text] [Related]
5. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
6. Value of ultrasonographic detection of normal ovarian tissue in the differential diagnosis of adnexal masses in pediatric patients.
Stankovic ZB; Bjelica A; Djukic MK; Savic D
Ultrasound Obstet Gynecol; 2010 Jul; 36(1):88-92. PubMed ID: 20069549
[TBL] [Abstract][Full Text] [Related]
7. Predictive values of the ultrasound parameters, CA-125 and risk of malignancy index in patients with ovarian cancer.
Antovska SV; Bashevska N; Aleksioska N
Klin Onkol; 2011; 24(6):435-42. PubMed ID: 22257232
[TBL] [Abstract][Full Text] [Related]
8. The value of detection of normal ovarian tissue (the 'ovarian crescent sign') in the differential diagnosis of adnexal masses.
Hillaby K; Aslam N; Salim R; Lawrence A; Raju KS; Jurkovic D
Ultrasound Obstet Gynecol; 2004 Jan; 23(1):63-7. PubMed ID: 14971002
[TBL] [Abstract][Full Text] [Related]
9. The risk of malignancy index in discrimination of adnexal masses.
Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
[TBL] [Abstract][Full Text] [Related]
10. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
[TBL] [Abstract][Full Text] [Related]
11. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.
Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L
J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390
[TBL] [Abstract][Full Text] [Related]
13. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
14. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
Moolthiya W; Yuenyao P
Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
[TBL] [Abstract][Full Text] [Related]
15. Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound.
Arun-Muthuvel V; Jaya V
Asian Pac J Cancer Prev; 2014; 15(6):2929-32. PubMed ID: 24761927
[TBL] [Abstract][Full Text] [Related]
16. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
17. Addition of parity to the risk of malignancy index score in evaluating adnexal masses.
Yavuzcan A; Çağlar M; Özgü E; Üstün Y; Dilbaz S; Ozdemir I; Güngör T; Kumru S
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):518-22. PubMed ID: 25510694
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses.
Morgante G; la Marca A; Ditto A; De Leo V
Br J Obstet Gynaecol; 1999 Jun; 106(6):524-7. PubMed ID: 10426607
[TBL] [Abstract][Full Text] [Related]
19. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
[TBL] [Abstract][Full Text] [Related]
20. [Effect of a risk of malignancy index in preoperative diagnosis of ovarian cancer].
Ma S; Shen K; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2001 Mar; 36(3):162-4. PubMed ID: 11783394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]